Perospirone in the treatment of patients with delirium

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 1, 2007, Pages 67-70

  Takeuchi, Takashi ^a   Furuta, Ko ^a   Hirasawa, Toshiyuki ^a   Masaki, Hidekazu ^a   Yukizane, Tomoaki ^a   Atsuta, Hidenori ^a   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atypical antipsychotics; Delirium; Perospirone

Indexed keywords

PEROSPIRONE;

AGED; AKATHISIA; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DATA ANALYSIS; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEART RATE; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; MALE; MAXIMUM PERMISSIBLE DOSE; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE;

AGED; ANTIPSYCHOTIC AGENTS; DELIRIUM; FEMALE; HUMANS; INDOLES; MALE; PSYCHIATRIC STATUS RATING SCALES; THIAZOLES;

EID: 33846169809     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01612.x     Document Type: Article

References (27)

1. Lipowski ZJ. Delirium: Acute Confusional States. Oxford University Press, New York, NY, 1990.
2. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am. J. Psychiatry 1999; 156 (Suppl. 5): 1-39.
3. Parellada E, Baeza I, de Pablo J, Martinez G. Risperidone in the treatment of patients with delirium. J. Clin. Psychiatry 2004; 65: 348-353.
4. Mittal D, Jimerson NA, Neely EP et al. Risperidone in the treatment of delirium: Results from a prospective open-label trial. J. Clin. Psychiatry 2004; 65: 662-667.
5. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301.
6. Horikawa N, Yamazaki T, Miyamoto K et al. Treatment for delirium with risperidone: Results of a prospective open trial with 10 patients. Gen. Hosp. Psychiatry 2003; 25: 289-292.
7. Liu CY, Juang YY, Liang HY, Lin NC, Yeh EK. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int. Clin. Psychopharmacol. 2004; 19: 165-168.
8. Sipahimalani A, Masand PS. Use of risperidone in delirium: Case reports. Ann. Clin. Psychiatry 1997; 9: 105-107.
9. Sipahimalani A, Masand PS. Treatment of delirium with risperidone. Int. J. Geriatr. Psychopharmacol. 1997; 1: 24-26.
10. Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L. Delirium in elderly patients treated with risperidone: A report of three cases. J. Clin. Psychopharmacol. 1998; 18: 171-172.
11. Sasaki Y, Matsuyama T, Inoue S et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J. Clin. Psychiatry 2003; 64: 1316-1321.
12. Kim KY, Bader GM, Kotlyar V, Gropper D. Treatment of delirium in older adults with quetiapine. J. Geriatr. Psychiatry Neurol. 2003; 16: 29-31.
13. Pae CU, Lee SJ, Lee CU, Lee C, Paik IH. A pilot trial of quetiapine for the treatment of patients with delirium. Hum. Psychopharmacol. 2004; 19: 125-127.
14. Torres R, Mittal D, Kennedy R. Use of quetiapine in delirium: Case reports. Psychosomatics 2001; 42: 347-349.
15. Schwarz TL, Masand PS. Treatment of delirium with quetiapine. Prim. Care Companion J. Clin. Psychiatry 2000; 2: 10-12.
16. Al-Samarrai S, Dunn J, Newmark T, Gupta S. Quetiapine for treatment-resistant delirium. Psychosomatics 2003; 44: 350-351.
17. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39: 422-430.
18. Kim KS, Pae CU, Chae JH, Bahk WM, Jun T. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin. Neurosci. 2001; 55: 515-519.
19. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med. 2004; 30: 444-449.
20. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43: 175-182.
21. Schwartz TL, Masand PS. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002; 43: 171-174.
22. Tune L. The role of antipsychotics in treating delirium. Curr. Psychiatry Rep. 2002; 4: 209-212.
23. Onrust SV, McClellan K. Perospirone. CNS Drugs 2001; 15: 329-337.
24. de Paulis T. Perospirone (Sumitomo Pharmaceuticals). Curr. Opin. Invest. Drugs 2002; 3: 121-129.
25. Iwakawa M, Terao T, Soya A et al. A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: Findings from neuroendocrine challenge tests. Psychopharmacology 2004; 176: 407-411.
26. Yoshino T, Nisijima K, Shioda K, Yui K, Katoh S. Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex. Neurosci. Lett. 2004; 364: 16-21.
27. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: Comparison with the delirium rating scale and the cognitive test for delirium. J. Neuropsychiatry Clin. Neurosci. 2001; 13: 229-242.